Cutler Group’s CONMED CNMD Stock Holding History

Cutler Group’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-1,279	Closed	-$51K	–	6589
2016 Q3	$51K	Buy	+1,279	New	+$54.3K	﹤0.01%	2440
2016 Q1	–	Sell	-250	Closed	-$11K	–	6556
2015 Q4	$11K	Buy	+250	New	+$10.8K	﹤0.01%	4019

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Cutler Group's CNMD Position: Q4 2016 in Review

Cutler Group sold out of CONMED (CNMD) in Q4 2016, closing a stake of 1,279 shares — an estimated $51K sold.

Cutler Group first reported a position in CNMD in Q4 2015 and held it in 2 quarters. The position peaked at $51K in Q3 2016. 147 funds tracked by Wall St. Rank hold CNMD as of Q4 2016.

Cutler Group reported no remaining CONMED position as of Q4 2016 after selling out during the quarter.
Cutler Group sold 1,279 CONMED shares in Q4 2016, an estimated $51K.
Cutler Group first reported a position in CONMED in Q4 2015 and held it in 2 quarters.
Cutler Group's CONMED position peaked at $51K in Q3 2016.
147 funds tracked by Wall St. Rank held CONMED as of Q4 2016.

Based on Cutler Group's 13F filing for Q4 2016, filed 12 Jan 2017.